Pfizer Inc. stock hits a 12-year low due to M&A missteps and high debt. Click here to find out why I rate PFE stock a Hold.

Dow's steep stock decline has boosted its dividend yield significantly. LyondellBasell's yield isn't too far behind Dow's, ...

Global pharmaceutical company Pfizer (NYSE:PFE) reported Q4 CY2024 results , with sales up 21.9% year on year to $17.76 billion. On the other hand, the company’s full-year revenue guidance of $ ...

Shares of Pfizer Inc. (PFE) slipped nearly 1.5% on Tuesday afternoon, even as the pharmaceutical giant posted a stronger-than-expected fourth-quarter report that energized retail traders.

In summary, income-focused investors may find Pfizer stock an attractive option for making a steady income of $100 per month ...

Pfizer's Q4 2024 results were higher than anticipated, with resilience in its underlying pharmaceutical business despite the headwind presented by the drop in COVID-19 revenue. The company ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals industry, including Pfizer (NYSE:PFE) and its peers. The branded ...

Pfizer's adjusted gross margins for FY2024 improved to 74% - this helped the firm beat the adjusted bottom-line figure by 37.2% in Q4 (actual $0.63 vs. expected $0.46): On a YoY basis, the ...

With a diverse portfolio of eight FDA-approved medications targeting neurological conditions, Supernus Pharmaceuticals ...